Moreover, mutations in GPC6 are associated with AD and ALS in genome-wide association studies (GWAS), and GPC6 exhibits increased expression and altered localization in spinal cord tissues from patients with ALS with TDP-43 proteinopathies33–37. This evidence concerns the gene GPC6 and Alzheimer disease.